UK markets open in 7 hours 50 minutes
NIKKEI 225
27,522.26 0.00 (0.00%) HANG SENG
24,965.55 +13.25 (+0.05%) CRUDE OIL
85.85 +0.71 (+0.83%) GOLD FUTURES
1,835.20 +3.40 (+0.19%) DOW
34,265.37 -450.03 (-1.30%) BTC-GBP
26,634.54 +653.37 (+2.51%)
Abeona Therapeutics Inc. (0H7R.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:10PM GMT
| Previous close | 0.2572 |
| Open | 0.2513 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.2316 - 0.2513 |
| 52-week range | 0.2316 - 0.2513 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5670 |
| Earnings date | 22 Mar 2022 - 28 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Down 15.2% in 4 Weeks, Here's Why Abeona Therapeutics (ABEO) Looks Ripe for a Turnaround
Abeona Therapeutics (ABEO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Simply Wall St.
Abeona Therapeutics (NASDAQ:ABEO) investors are sitting on a loss of 90% if they invested three years ago
It's not possible to invest over long periods without making some bad investments. But really bad investments should be...
- Zacks
Moving Average Crossover Alert: Abeona Therapeutics (ABEO)
Abeona Therapeutics (ABEO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
© 2022 Yahoo. All rights reserved.
